Management of carotid restenosis

B K Lal1, R W Hobson

  • 1Division of Vascular Surgery, Department of Surgery UMDNJ-New Jersey Medical School, Newark, 07107, USA.

Insights

Recurrent carotid stenosis after stenting or endarterectomy is a growing concern. This review provides evidence-based recommendations for diagnosing and managing this condition.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Interventional Cardiology

Background:

  • Carotid endarterectomy is the standard for cerebral revascularization in high-grade carotid artery stenosis.
  • Carotid artery stenting is a less invasive alternative, showing feasibility and safety, especially in high-risk patients.
  • Increasing rates of carotid stenting predict a rise in in-stent restenosis cases.

Purpose of the Study:

  • To analyze current information on recurrent carotid stenosis after endarterectomy and stenting.
  • To address the controversy surrounding the clinical significance and management of recurrent stenosis.
  • To present evidence-based recommendations for diagnosis and management.

Main Methods:

  • Literature review of current information on recurrent carotid stenosis.
  • Analysis of data regarding clinical significance, natural history, and management thresholds.
  • Synthesis of evidence to formulate recommendations.

Main Results:

  • Carotid stenting is increasingly performed, leading to more in-stent restenosis cases.
  • Significant controversy exists regarding the optimal management of recurrent carotid stenosis.
  • Evidence-based recommendations are needed for diagnosis and intervention.

Conclusions:

  • Recurrent carotid stenosis is an emerging clinical challenge following endarterectomy and stenting.
  • A clear understanding of its natural history and management is crucial.
  • Evidence-based guidelines are essential for optimal patient care.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...